Weidong Lu is a research faculty member at NESA, and a researcher and staff acupuncturist at Dana-Farber Cancer Institute’s Zakim Center. Weidong Lu received his medical degree (MB) from Zhejiang College of Traditional Chinese Medicine in 1983 and his MPH from the Harvard School of Public Health. Weidong Lu taught and conducted research in China before coming to the United States in 1991. As part of the NESA Acupuncture Research Collaborative, he is a co-leader of the clinical trial entitled Acupuncture of Chemotherapy-Induced Neutropenia. He is also the co-investigator of an NIH-funded trial evaluating the effects of acupuncture on the quality of life in late-stage cancer patients, and has served as a consultant to Harvard Medical School’s Osher Institute for numerous studies. He maintains a private practice in the NESA clinic. Weidong Lu is also chairman of the Massachusetts Board of Registration in Medicine’s Committee on Acupuncture.

Courses:

• Clinical Pharmacology